How important is ‘implementation science’ for national genomics policy?
Field | Value | Language |
dc.contributor.author | Gul, Hossai | |
dc.contributor.author | Long, Janet | |
dc.contributor.author | Best, Stephanie | |
dc.contributor.author | Braithwaite, Jeffrey | |
dc.date.accessioned | 2019-06-14 | |
dc.date.available | 2019-06-14 | |
dc.date.issued | 2019-06-14 | |
dc.identifier.uri | http://hdl.handle.net/2123/20564 | |
dc.description.abstract | The traditional translation pathway of ‘bench- to-bedside’ will not be enough to integrate genomics into routine clinical care. It requires the use of validated and systematic ‘implementation science’ methods. Within the pipeline of evidence-based translation of new technologies, implementation science is the phase that informs policy regarding the appropriateness, adoption, feasibility, acceptability, fidelity, penetration, and sustainability of technologies being transferred from research settings into the real world. Without implementation science, barriers can emerge unchecked and key drivers neglected. Health services researchers now have a large knowledge base which identifies barriers and drivers for implementation of new technologies into healthcare. | en_AU |
dc.subject | Implementation | en_AU |
dc.subject | genomics | en_AU |
dc.subject | policy | en_AU |
dc.subject | health | en_AU |
dc.subject | innovation | en_AU |
dc.title | How important is ‘implementation science’ for national genomics policy? | en_AU |
dc.type | Other | en_AU |
dc.contributor.department | Menzies Centre for Health Policy | en_AU |
Associated file/s
Associated collections